Poniard stock to split one-for-six

By Lisa Kerner

Charlotte, N.C., Sept. 22 - Poniard Pharmaceuticals, Inc. shareholders approved a one-for-six reverse split of the company's common stock, effective the opening of trading on Sept. 25.

On that date, the South San Francisco, Calif., specialty pharmaceutical company's common stock will begin trading on a split-adjusted basis under the symbol "PARDD" for 20 trading days and then resume trading under the symbol "PARD."

The split is designed to generate greater interest in Poniard securities among new investors and analysts, as well as to bring the number of shares outstanding into more appropriate alignment with the company's size, officials said.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.